Schedule 13D ownership disclosure
Horizon Pharma plc
Security class unavailable · CUSIP: G4617B105
Event date: 2015-02-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-076768
- Form type
- SC 13D
- Filer
- Horizon Therapeutics Public Ltd Co
- CIK
- CIK 1492426
- Filed
- Mar 04, 2015
- Reporting period
- Feb 27, 2015
- Description
- Schedule 13D beneficial ownership